The BMJ brings you interviews with the people who are shaping medicine and science around the world.
…
continue reading
Contenuto fornito da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Lessons from UKCTOCS, a large-scale trial in ovarian cancer screening
Manage episode 399359963 series 1631392
Contenuto fornito da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS faced in its design, conduct an analysis, and how the team addressed them. Further information is available on the UKCTOCS website at https://ukctocs.mrcctu.ucl.ac.uk/ Listen to the episode about the UKCTOCS trial results at https://bit.ly/48pK94J For questions or feedback on the series, message us at [email protected] For more information and to access the transcript: https://bit.ly/45XRyWT As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
…
continue reading
25 episodi
Manage episode 399359963 series 1631392
Contenuto fornito da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS faced in its design, conduct an analysis, and how the team addressed them. Further information is available on the UKCTOCS website at https://ukctocs.mrcctu.ucl.ac.uk/ Listen to the episode about the UKCTOCS trial results at https://bit.ly/48pK94J For questions or feedback on the series, message us at [email protected] For more information and to access the transcript: https://bit.ly/45XRyWT As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
…
continue reading
25 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.